Journals
Publish with us
Publishing partnerships
About us
Blog
The Scientific World Journal
Journal overview
For authors
For reviewers
For editors
Table of Contents
Special Issues
The Scientific World Journal
/
2012
/
Article
/
Fig 1
/
Clinical Study
Temozolomide as Second or Third Line Treatment of Patients with Neuroendocrine Carcinomas
Figure 1
Kaplan-Meier survival curves for patients with Ki-67 index <50% versus ≥50%.